Ipca Laboratories Ltd Share Price – NSE /  BSE

Pharmaceuticals, Small Cap

Ipca Laboratories Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 1879.3, up 2.11% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.45% on the day, quoting at 24160.1. The Sensex is at 77455.4, up 0.52%. Ipca Laboratories Ltd has risen around 21.23% in last one month.

Meanwhile, Nifty Pharma index of which Ipca Laboratories Ltd is a constituent, has risen around 7.92% in last one month and is currently quoting at 25907.1, up 0.64% on the day. The volume in the stock stood at 1.72 lakh shares today, compared to the daily average of 2.43 lakh shares in last one month.

The PE of the stock is 40.42 based on TTM earnings ending March 26.

Powered by Capital Market - Live News

Ipca Laboratories announced that the Annual General Meeting(AGM) of the company will be held on 13 August 2026.

Ipca Laboratories Ltd is up for a third straight session in a row. The stock is quoting at Rs 1831.5, up 2.44% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.04% on the day, quoting at 24216.7. The Sensex is at 77693.16, up 0.16%. Ipca Laboratories Ltd has risen around 16.23% in last one month.

Meanwhile, Nifty Pharma index of which Ipca Laboratories Ltd is a constituent, has risen around 5.67% in last one month and is currently quoting at 25674.1, down 0.32% on the day. The volume in the stock stood at 2.25 lakh shares today, compared to the daily average of 2.31 lakh shares in last one month.

The PE of the stock is 39.27 based on TTM earnings ending March 26.

Powered by Capital Market - Live News

The board of Ipca Laboratories at its meeting held on 26 June 2026 has approved the scheme of amalgamation of Krebs Biochemicals & Industries (Transferor Company) with the company (Transferee Company) under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013.